Literature DB >> 18381576

Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells.

Toyoshi Endo1, Kazuyasu Ohta, Tetsuro Kobayashi.   

Abstract

CONTEXT: Development of calcifying foci is a common finding in human thyroid papillary carcinoma, but its mechanisms remain unknown.
OBJECTIVE: We therefore investigated whether osteocalcin and/or Cbfa-1 genes are expressed in malignant thyroid epithelial cells. We also studied the effects of Cbfa-1 on the expression of osteoblast-specific and thyrotropin receptor genes in thyrocytes.
RESULTS: The human thyroid papillary carcinoma cell line BHP18-21 expresses bone-type osteocalcin mRNA at higher levels than in MG63 osteosarcoma cells. Northern blot analysis and EMSA using nuclear extracts from BHP18-21 cells and FRTL-5 cells demonstrated that cells of thyroid epithelial origin expressed Cbfa-1/Runx2, the main transcription factor for the expression of osteocalcin. When we transfected pcDNA3.1-human Cbfa-1 into FRTL-5 cells, Cbfa-1 increased the gene expression of alkaline phosphatase, type I collagen, and osteocalcin but suppressed the expression of thyrotropin receptor. We then stained the calcified regions of human papillary thyroid carcinoma tissues with antiosteocalcin antibody and found that malignant cells, as well as follicular epithelial cells, were immunopositive for osteocalcin. Northern blot analysis revealed that the Cbfa-1/Runx2 gene was strongly expressed in tissues from four cases of surgically resected papillary carcinoma.
CONCLUSIONS: Thyrocytes share characteristics with osteoblasts. Cbfa-1 may play a role in calcification processes in human thyroid papillary carcinoma tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381576     DOI: 10.1210/jc.2007-2805

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer.

Authors:  Zhengjun Yang; Bin Zhang; Bowen Liu; Yegong Xie; Xuchen Cao
Journal:  Tumour Biol       Date:  2015-01-22

2.  Runx2 expression: A mesenchymal stem marker for cancer.

Authors:  Maria Teresa Valenti; Paola Serafini; Giulio Innamorati; Anna Gili; Samuele Cheri; Claudio Bassi; Luca Dalle Carbonare
Journal:  Oncol Lett       Date:  2016-09-23       Impact factor: 2.967

3.  Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.

Authors:  Valentina Sancisi; Gloria Borettini; Sally Maramotti; Moira Ragazzi; Ione Tamagnini; Davide Nicoli; Simonetta Piana; Alessia Ciarrocchi
Journal:  J Clin Endocrinol Metab       Date:  2012-07-20       Impact factor: 5.958

4.  Runx2 deficiency in mice causes decreased thyroglobulin expression and hypothyroidism.

Authors:  Toyoshi Endo; Tetsuro Kobayashi
Journal:  Mol Endocrinol       Date:  2010-04-07

5.  Association between collagen type XI α1 gene polymorphisms and papillary thyroid cancer in a Korean population.

Authors:  Hae Jeong Park; Bong-Keun Choe; Su Kang Kim; Hyun-Kyung Park; Jong Woo Kim; Joo-Ho Chung; Il Ki Hong; Dae Han Chung; Kee Hwan Kwon
Journal:  Exp Ther Med       Date:  2011-07-14       Impact factor: 2.447

6.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

Review 7.  The RUNX family in breast cancer: relationships with estrogen signaling.

Authors:  N-O Chimge; B Frenkel
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

8.  Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.

Authors:  Frances E Carr; Phillip W L Tai; Michael S Barnum; Noelle E Gillis; Katherine G Evans; Thomas H Taber; Jeffrey H White; Jennifer A Tomczak; Diane M Jaworski; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Endocrinology       Date:  2016-06-02       Impact factor: 4.736

9.  The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.

Authors:  Claudia M J Lucero; Oscar A Vega; Mariana M Osorio; Julio C Tapia; Marcelo Antonelli; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

10.  Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.

Authors:  T Ozaki; D Wu; H Sugimoto; H Nagase; A Nakagawara
Journal:  Cell Death Dis       Date:  2013-04-25       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.